Navigation Links
Perrigo Announces FDA Final Approval for Polyethylene Glycol 3350
Date:10/6/2009

ALLEGAN, Mich., Oct. 6 /PRNewswire-FirstCall/ -- Perrigo Company (Nasdaq: PRGO;TASE) today announced that it has received final approval from the U.S. Food and Drug Administration for its Abbreviated New Drug Application for over-the-counter (OTC) Polyethylene Glycol 3350, Powder for Solution. Perrigo is expecting to begin shipping immediately.

The product will be marketed under store brand labels and is comparable to Schering-Plough HealthCare Products' MiraLAX(®), indicated for the treatment of occasional constipation. Estimated brand sales for the product for the last 12 months ending August 28, 2009 were $200 million.

Perrigo's Chairman and CEO Joseph C. Papa stated, "This is another example of Perrigo's continuing commitment to innovation and bringing new products to market. It is investments like this that help save OTC healthcare consumers more than an estimated $1 billion annually when compared to the higher priced national brands."

Perrigo Company is a leading global healthcare supplier that develops, manufactures and distributes OTC and generic prescription pharmaceuticals, nutritional products, active pharmaceutical ingredients (API) and consumer products. The Company is the world's largest manufacturer of OTC pharmaceutical products for the store brand market. The Company's primary markets and locations of manufacturing and logistics operations are the United States, Israel, Mexico and the United Kingdom. Visit Perrigo on the Internet (http://www.perrigo.com).

Note: Certain statements in this press release are forward-looking statements within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended, and are subject to the safe harbor created thereby. These statements relate to future events or the Company's future financial performance and involve known and unknown risks, uncertainties and other factors that may cause the
'/>"/>

SOURCE Perrigo Company
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Perrigo Announces Approval for Over-the-Counter Childrens Cetirizine Oral Solution
2. Perrigo and Partner Cobrek Confirms Filing for Generic Version of Evoclin(R) and Announcement of Lawsuit by Stiefel
3. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
4. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
5. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
6. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
7. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
8. Phosphagenics Announces Positive Phase 1b Transdermal Insulin Clinical Trial Results
9. Xenomics Announces Implementation of its First Diagnostic Test for Acute Myeloid Leukemia Into Clinical Practice
10. Emisphere Technologies, Inc. Announces 2007 Second Quarter Financial Results
11. Amicus Therapeutics Announces Second Quarter 2007 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/11/2014)... DALLAS , July 11, 2014 ... report "Scintillator Market by Composition of Material, Application ... and others), End Product (Personal Instrument, Hand-Held Instruments, ... Forecast and Analysis to 2013 - 2020", published by MarketsandMarkets, ... a CAGR of 5.62% from 2014 to 2020, ...
(Date:7/11/2014)... , July 11, 2014  Australian drug delivery company, ... it has raised A$19.3 million via a placement of ... , the U.S., Asia ... from a share purchase plan (SPP) to be offered ... be made in two tranches. "This capital ...
(Date:7/11/2014)... 2014 Research and Markets ( http://www.researchandmarkets.com/research/tjlw9k/immunoprotein ... "Immunoprotein Diagnostic Testing Market - Forecasts to 2019: ... 6% and is expected to be valued at ... http://photos.prnewswire.com/prnh/20130307/600769 ... been segmented according to immunoprotein types which include ...
Breaking Medicine Technology:Scintillator Market will be worth $479.16 Million by 2020 2Scintillator Market will be worth $479.16 Million by 2020 3Scintillator Market will be worth $479.16 Million by 2020 4Phosphagenics' A$19.3 million Capital Raising 2Phosphagenics' A$19.3 million Capital Raising 3Immunoprotein Diagnostic Testing Market - Forecasts to 2019: Expected to grow at the highest CAGR of 6% and is expected to be valued at USD 4,943.0 million 2
(Date:7/12/2014)... rise in the number of mobility devices around the ... suit the upsurge. Virtualization has become a growing trend ... The data traffic has increased by several folds with ... in larger and more complex networks. These global factors ... , The North American (NA) region is expected to ...
(Date:7/12/2014)... The "North American ... Market by Angioplasty Balloon (Plain/Old, Cutting), ... IVC Filter (Retrievable), Endovascular Stent Graft ... studies the major market drivers, restraints, ... Canada. , Browse 108 market data ...
(Date:7/12/2014)... July 12, 2014 The Security Analytics ... 2013 to $3,376.6 million by 2019, at an expected ... 2019. The challenges to counter the increasing number of ... of outdated cyber defense systems in organizations are enormous. ... and remodeling their existing architecture to develop better and ...
(Date:7/12/2014)... Casinos in Australia have ... from international and online casinos. Revenue is estimated to ... years through 2014-15. Greater per capita gambling expenditure has ... Rises in discretionary income levels have also assisted revenue ... items such as casino gambling services. Revenue is estimated ...
(Date:7/12/2014)... "The second toes cross over the big toes on ... said an inventor from East Hartford, Conn. This gave him ... , He then created a prototype of the Comfort Sock, ... big toes from overlapping. This avoids discomfort and pain, which ... to use, it's ideal for people with foot problems, athletes ...
Breaking Medicine News(10 mins):Health News:North America Software Defined Network (SDN) Market Worth $1,443.8 Million by 2019 - New Report by MicroMarket Monitor 2Health News:North America Software Defined Network (SDN) Market Worth $1,443.8 Million by 2019 - New Report by MicroMarket Monitor 3Health News:North America Software Defined Network (SDN) Market Worth $1,443.8 Million by 2019 - New Report by MicroMarket Monitor 4Health News:North America Software Defined Network (SDN) Market Worth $1,443.8 Million by 2019 - New Report by MicroMarket Monitor 5Health News:North American Interventional Cardiology & Peripheral Vascular Devices Market - New Report by MarketsandMarkets 2Health News:North American Interventional Cardiology & Peripheral Vascular Devices Market - New Report by MarketsandMarkets 3Health News:North American Interventional Cardiology & Peripheral Vascular Devices Market - New Report by MarketsandMarkets 4Health News:North American Interventional Cardiology & Peripheral Vascular Devices Market - New Report by MarketsandMarkets 5Health News:North America Security Analytics Market Worth $1,215.2 Million by 2019 - New Report by MicroMarket Monitor 2Health News:North America Security Analytics Market Worth $1,215.2 Million by 2019 - New Report by MicroMarket Monitor 3Health News:North America Security Analytics Market Worth $1,215.2 Million by 2019 - New Report by MicroMarket Monitor 4Health News:Casinos in Australia Industry Market Research Report Now Updated by IBISWorld 2Health News:Casinos in Australia Industry Market Research Report Now Updated by IBISWorld 3Health News:Casinos in Australia Industry Market Research Report Now Updated by IBISWorld 4
... , , , ... brush and the expression of dance and movement have an incredible ... as art therapy, dance and movement therapy and equine therapy, have ... issues including substance abuse, eating disorders, abuse issues, depression, anxiety, relationship ...
... , ALBANY, N.Y., July 31 ... New York throughout the week of August 3 - 7 ... New Yorkers access information on programs that provide prescription medicines for ... 8.2 percent, compared to 5.2 percent a year ago, the ...
... Healthy African American Families, Familia Unida and ... Practices that Deny California Communities Access ... LOS ANGELES, July 31 California patient advocacy organizations Healthy ... a letter to California Attorney General Jerry Brown requesting an ...
... coverage, for health effects, , FRIDAY, July 31 (HealthDay News) ... obesity in the United States have tripled, putting increasing numbers ... a new study. , Researchers looked at National Health and ... years, and found that the prevalence of severe obesity increased ...
... journal of the American Academy of Ophthalmology, reports on ... macular edema as well as people who develop cystoid ... to treat some cancers. Another study describes methods that ... patients. DR is the major threat to vision in ...
... Ohio, July 31 PharmaForce, Inc., announced today that it ... (FDA) for its Abbreviated New Drug Application (ANDA) for Betamethasone ... version of Schering Corporation,s Celestone(R) Soluspan(R). , , ... is marketed in a 6 mg/mL (3 mg base betamethasone/mL; ...
Cached Medicine News:Health News:The Healing Power of Art, Dance and Expression 2Health News:The Healing Power of Art, Dance and Expression 3Health News:Partnership for Prescription Assistance Prepared to Help New York Workers Hurt by Recession 2Health News:Partnership for Prescription Assistance Prepared to Help New York Workers Hurt by Recession 3Health News:Minority and Women's Advocacy Groups Send Letter to California Attorney General Jerry Brown Requesting Investigation Into Discrimination by Health Insurance Companies 2Health News:Minority and Women's Advocacy Groups Send Letter to California Attorney General Jerry Brown Requesting Investigation Into Discrimination by Health Insurance Companies 3Health News:Minority and Women's Advocacy Groups Send Letter to California Attorney General Jerry Brown Requesting Investigation Into Discrimination by Health Insurance Companies 4Health News:More Kids Becoming Severely Obese 2Health News:Cancer treatment controls macular edema related to diabetes and to cataract surgery 2Health News:Cancer treatment controls macular edema related to diabetes and to cataract surgery 3Health News:PharmaForce Inc. Receives FDA Approval for First Generic of Betamethasone Sodium Phosphate and Betamethasone Acetate Injectable Suspension, USP 2
Barkan Goniotomy Knife: 4" (11.4 cm), 2.5 mm blade....
... proven that the management of diabetes in order ... is the most effective way to reduce or ... at maintaining or improving a diabetes patients quality ... , ,These have been the guiding factors ...
... diabetes requires making decisions about insulin dosages ... These decisions are guided by data from ... and by the patterns that can be ... Providers when the data is presented in ...
... Photocoagulator - Portable and rugged solid-state photocoagulator ... and operating room. Built to high-duty cycle ... most demanding environments, the Novus Verdi can ... full line of accessories for private practice ...
Medicine Products: